BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 7522284)

  • 1. Long-term efficacy of amlodipine in patients with severe coronary artery disease.
    Navarro Estrada JL; Oliveri R
    J Cardiovasc Pharmacol; 1993; 22 Suppl A():S24-8. PubMed ID: 7522284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Comparative study to assess the efficacy and adverse effects of amlodipine and nifedipine retard in patients with stable exertional angina and hypertension].
    Witkowska M; Tracz W; Kubler G; Negrusz-Kawecka M; Hlawaty M; Olszowska M; Salamon P
    Przegl Lek; 1997; 54(5):324-8. PubMed ID: 9380807
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antianginal efficacy of ranolazine when added to treatment with amlodipine: the ERICA (Efficacy of Ranolazine in Chronic Angina) trial.
    Stone PH; Gratsiansky NA; Blokhin A; Huang IZ; Meng L;
    J Am Coll Cardiol; 2006 Aug; 48(3):566-75. PubMed ID: 16875985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A haemodynamic dose finding study with a new slow-calcium channel blocker (amlodipine) in coronary artery disease.
    Frais MA; Silke B; Verma SP; Sharma SK; Reynolds G; Jackson NC; Taylor SH
    Herz; 1986 Dec; 11(6):351-8. PubMed ID: 2950040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anti-ischaemic properties of amlodipine, a new calcium antagonist, in patients with severe coronary artery disease: a prospective trial.
    Navarro Estrada J; Saglietti H; Dimarco M; Casabé H; Oliveri R
    Postgrad Med J; 1991; 67 Suppl 5():S52-3. PubMed ID: 1839441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amlodipine monotherapy in chronic stable angina.
    Petkar S; Sethi KK; Sudha R; Sharma SM; Arora R; Khalilullah M
    Indian Heart J; 1994; 46(2):85-8. PubMed ID: 7989081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of amlodipine and lacidipine on heart rate variability in hypertensive patients with stable angina pectoris and isolated left ventricular diastolic dysfunction.
    Zaliūnas R; Brazdzionyte J; Zabiela V; Jurkevicius R
    Int J Cardiol; 2005 Jun; 101(3):347-53. PubMed ID: 15907400
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The development of tolerance to continuous transdermal nitroglycerin therapy in patients with angina of effort and mixed angina].
    Cianfrocca C; Sabia R; Zoboli S; Bugiardini R
    G Ital Cardiol; 1993 May; 23(5):439-49. PubMed ID: 8339869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amlodipine in angina pectoris: effect on maximal and submaximal exercise performance.
    Kinnard DR; Harris M; Hossack KF
    J Cardiovasc Pharmacol; 1988; 12 Suppl 7():S110-3. PubMed ID: 2467119
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L; Hiremath ; Kerkar PG; Manade VG
    J Assoc Physicians India; 2004 Mar; 52():197-202. PubMed ID: 15636308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Long-term treatment of stable angina pectoris with gallopamil].
    Pupita G; Mattei O; Mazzara D; Centanni M; Ferretti GF; Rimatori C; Dessì-Fulgheri P; Rappelli A; Russo P
    G Ital Cardiol; 1992 Sep; 22(9):1049-56. PubMed ID: 1291422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute and chronic efficacy of low-dose nitroglycerin patches in stable angina pectoris.
    Rezaković DE; Lakatos S; Stalec J; Pavicić L
    Z Kardiol; 1986; 75 Suppl 3():90-5. PubMed ID: 3099489
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and tolerability of combination therapy with valsartan plus hydrochlorothiazide compared with amlodipine monotherapy in hypertensive patients with other cardiovascular risk factors: the VAST study.
    Ruilope LM; Malacco E; Khder Y; Kandra A; Bönner G; Heintz D
    Clin Ther; 2005 May; 27(5):578-87. PubMed ID: 15978306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of buccal nitroglycerin on pulmonary artery pressure at rest and during exercise: a comparison with sublingual nitroglycerin in patients with coronary artery disease.
    Langbehn AF; Sheikhzadeh A; Stierle U; Thoran P
    Z Kardiol; 1983; 72 Suppl 3():239-45. PubMed ID: 6421010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of hypertension associated with stable angina pectoris: favourable interaction between new metoprolol formulation (OROS) and nifedipine.
    Di Somma S; de Divitiis M; Bertocchi F; Carotenuto A; Cudemo G; Petitto M; Napodano M; de Divitiis O
    Cardiologia; 1996 Jul; 41(7):635-43. PubMed ID: 8831181
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sustained effects of transdermal nitroglycerin in patients with angina pectoris.
    Kapoor AS; Dang NS; Reynolds RD
    Clin Ther; 1985; 7(6):674-9. PubMed ID: 3935313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in Korean adults with mild to moderate hypertension.
    Kim SH; Kim YD; Lim DS; Yoon MH; Ahn YK; On YK; Lee JW; Kim IJ; Park JB; Kim JJ; Chung WS; Yang JY; Seo HS; Shin EK; Kim HS;
    Clin Ther; 2007 Sep; 29(9):1924-36. PubMed ID: 18035192
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stent implantation for the unprotected left main coronary artery. The long-term outcome of 62 patients.
    Peszek-Przybyła E; Buszman P; Białkowska B; Zurakowski L; Banasiewicz-Szkróbka I; Debiński M; Tendera M
    Kardiol Pol; 2006 Jan; 64(1):1-6; discussion 7. PubMed ID: 16444619
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Evaluation of amlodipine in stable effort angina. Comparison with diltiazem in terms of efficacy, tolerability and maintenance of the anti-ischemic action 24 hours after the last dose].
    Marchand X; Tibi T; Bernaud C; Morand P
    Ann Cardiol Angeiol (Paris); 1996 Feb; 45(2):74-82. PubMed ID: 8734139
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.